← Leaderboards
Debby Ngo
Massachusetts General Hospital
$815,069
Attributed
$815,069
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164.1K · FY2012–16$200K$150K$100K$50K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$815,069 · 1
By mechanism
K01$815,069 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Gregory Dyer Lewis$6,901,253
- Paul B Yu$13,557,400
- Charles A Hales$9,896,268
- Braden Kuo$7,375,946
- Filip K Swirski$20,484,870
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsBaseBiologyBlood VesselsCardiopulmonaryCareerCareer DevelopmentCellsCellular BiologyChronicCohortCongestive Heart FailureCritical CareDiagnosisEndothelium-Dependent Relaxing FactorsEnvironmentEnzymesExercise Stress TestFacultyFellowshipFosteringFoundationsGeneral HospitalsAdvisory Committees
Grant awards (6)
The Kynurenine Pathway in Pulmonary Arterial Hypertension$150,882
K01 · FY2016 · GM · contact PI
The Kynurenine Pathway in Pulmonary Arterial Hypertension$13,230
K01 · FY2016 · GM · contact PI
The Kynurenine Pathway in Pulmonary Arterial Hypertension$164,112
K01 · FY2015 · GM · contact PI
The Kynurenine Pathway in Pulmonary Arterial Hypertension$164,112
K01 · FY2014 · GM · contact PI
The Kynurenine Pathway in Pulmonary Arterial Hypertension$159,189
K01 · FY2013 · GM · contact PI
The Kynurenine Pathway in Pulmonary Arterial Hypertension$163,544
K01 · FY2012 · GM · contact PI